|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows – operating activities: | |||||
| Net earnings/(loss) | |||||
| Adjustments to reconcile net earnings/(loss) to net cash provided/(used) by operating activities: | |||||
| Non-cash items – | |||||
| Share-based plans expense | |||||
| Treasury shares issued for 401(k) contribution | |||||
| Depreciation and amortization | |||||
| Investment/asset impairment charges, net | |||||
| Customer financing valuation adjustments | |||||
| Gain on dispositions, net | |||||
| 777X and 767 reach-forward losses | |||||
| Other charges and credits, net | |||||
| Changes in assets and liabilities – | |||||
| Accounts receivable | |||||
| Unbilled receivables | |||||
| Advances and progress billings | |||||
| Inventories | |||||
| Other current assets | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Income taxes receivable, payable and deferred | |||||
| Other long-term liabilities | |||||
| Pension and other postretirement plans | |||||
| Financing receivables and operating lease equipment, net | |||||
| Other | |||||
| Net cash provided/(used) by operating activities | |||||
| Cash flows – investing activities: | |||||
| Payments to acquire property, plant and equipment | |||||
| Proceeds from disposals of property, plant and equipment | |||||
| Acquisitions, net of cash acquired | |||||
| Proceeds from dispositions | |||||
| Contributions to investments | |||||
| Proceeds from investments | |||||
| Supplier notes receivable | |||||
| Repayments on supplier notes receivable | |||||
| Purchase of distribution rights | |||||
| Other | |||||
| Net cash provided/(used) by investing activities | |||||
| Cash flows – financing activities: | |||||
| New borrowings | |||||
| Debt repayments | |||||
| Common stock issuance, net of issuance costs | |||||
| Mandatory convertible preferred stock issuance, net of issuance costs | |||||
| Stock options exercised | |||||
| Employee taxes on certain share-based payment arrangements | |||||
| Dividends paid on Mandatory convertible preferred stock | |||||
| Other | |||||
| Net cash (used)/provided by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net (decrease)/increase in cash & cash equivalents, including restricted | |||||
| Cash & cash equivalents, including restricted, at beginning of year | |||||
| Cash & cash equivalents, including restricted, at end of year | |||||
| Less restricted cash & cash equivalents, included in Investments | |||||
| Cash and cash equivalents at end of year |
Loading...